BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17239344)

  • 1. p21waf1/Cip1 partially mediates apoptosis in hepatocellular carcinoma cells.
    Svechnikova I; Ammerpohl O; Ekström TJ
    Biochem Biophys Res Commun; 2007 Mar; 354(2):466-71. PubMed ID: 17239344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
    Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
    Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
    Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
    Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
    Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
    Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.
    Gray SG; Yakovleva T; Hartmann W; Tally M; Bakalkin G; Ekström TJ
    Exp Cell Res; 1999 Dec; 253(2):618-28. PubMed ID: 10585285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells].
    Lv BH; Zhang L; Zhu CC; Liu J
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
    Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
    Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of overexpression of p21WAF1/CIP1 on the malignant phenotype and apoptosis of human hepatocellular carcinoma cells].
    Yang F; Wang W
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):99-101. PubMed ID: 11776868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
    Lai PB; Chi TY; Chen GG
    Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf.
    Wagner S; Roemer K
    Biochem Pharmacol; 2005 Apr; 69(7):1059-67. PubMed ID: 15763542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crude extracts of Euchresta formosana radix induce cytotoxicity and apoptosis in human hepatocellular carcinoma cell line (Hep3B).
    Hsu SC; Kuo CL; Lin JP; Lee JH; Lin CC; Su CC; Lin HJ; Chung JG
    Anticancer Res; 2007; 27(4B):2415-25. PubMed ID: 17695533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels.
    Nawrocki ST; Carew JS; Douglas L; Cleveland JL; Humphreys R; Houghton JA
    Cancer Res; 2007 Jul; 67(14):6987-94. PubMed ID: 17638911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell].
    Wang CT; Meng M
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):927-9. PubMed ID: 17650409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis.
    Krämer OH; Knauer SK; Zimmermann D; Stauber RH; Heinzel T
    Oncogene; 2008 Jan; 27(6):732-40. PubMed ID: 17653085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
    Vinodhkumar R; Song YS; Devaki T
    Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.